Resources
About Us
Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal) Material (Silicon, Hydroxyapatite) Application (Prosthesis, Ocuplasty, Glaucoma Surgery) End User – Global Forecast to 2031
Report ID: MRHC - 1041245 Pages: 240 Sep-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample ReportThe Ocular Implants Market is expected to reach $23.43 billion by 2031, at a CAGR of 6.1% from 2024 to 2031. The growth of the ocular implants market is driven by the increasing geriatric population coupled with the high prevalence of eye diseases, the rising adoption of minimally invasive surgeries, increasing healthcare expenditure, technological advancements in ocular implants, increasing accident cases, and the rising need for ocular implants. However, the risk of post-surgery infection and inflammation, lack of skilled ophthalmic surgeons, and strict regulations and approval processes restrain the growth of this market.
Additionally, the lack of awareness in rural areas, technological complexities, high implant costs, and increasing product recalls are major challenges for the players operating in this market. Furthermore, biomaterial-based ocular implants, AI-driven 3D printed prosthetic eyes, and drug-eluting implants are trends in the ocular implants market.
The rising geriatric population has become a concern in several countries globally. This increase is attributed to the increasing life expectancy, declining fertility rates, and improvements in the quality of healthcare resulting in greater survival rates. According to the World Health Organization (WHO), by 2030, one in 6 people globally will be aged 60 years or above. In 2022, the elderly population reached nearly 1.4 billion from 1 billion in 2020. This number is expected to increase further to 2.1 billion by 2050.
The geriatric population is more prone to eye diseases due to weakened immune systems, age-related macular degeneration (AMD), and other diseases. Also, cataracts impact more than 20.5 million Americans aged 40 and older, and 6.1 million Americans have had cataract surgery. (Source: American Academy of Ophthalmology). Such instances are expected to drive the growth of the ocular implants market.
The number of companies that have developed ocular implants has increased significantly over the past decade. Recently, material selection and implant design criteria have progressed from nonporous polymeric spheres to devices with more advanced shapes and complicated functions for ensuring improved clinical results. Due to their highly interconnected design, polymeric and ceramic implants have gained popularity for fibrovascular ingrowth, with depleted obstacle rates provided with improved options for setting prosthetic eye mobility. Additionally, numerous bio-ceramic compositions are currently demonstrated and have resulted in the capacity to bind to soft tissue and promote angiogenesis, making these materials compatible with several soft tissue applications, including eye operation that was earlier unimaginable. Such advancements are expected to drive the ocular implants market.
Click here to: Get Free Sample Pages of this Report
Prosthetic eyes designed and made by artificial intelligence (AI) and 3D-printed take approximately 80% less time to manufacture as compared to traditional manufacturing methods from human specialists. Also, a small trial indicates that prosthetic 3D printed eye has well-fitting advantages in most cases. Also, according to a November 2021 report from University College London, nearly 0.1% of the population in the U.K. need a prosthesis (around 70,000 people), and the prosthetic eye is to be replaced around every five years with a unique socket. For instance, in February 2024, researchers from Fraunhofer Institute for Computer Graphics Research IGD (Germany) collaborated with Ocupeye Ltd. (U.K.) to develop a new AI-driven technique for 3D printing prosthetic eyes. Such instances are expected to drive the market for ocular implants.
In the cornea, tissue engineering is crucial for maintaining the transparent barrier between the eye and the environment and protecting the eye from microbes and dryness. In severe corneal diseases, transparency is no longer maintained, which is generally because of a malfunction of one of the three parts of the cornea. Thus, developments in tissue engineering have focused on reconstructing the damaged part to restore the transparency of the entire cornea. These strategies of regenerating the corneal epithelium are expected to be clinically approved in the near future for various eye-related concerns, which is expected to drive the growth of the ocular implants market.
The eye is amongst the most sensitive organs in the body and comprises various defense and barrier mechanisms for its protection from the environment. This leads to the challenge of delivering the drugs to different parts of the eye and the treatment of ocular diseases due to their anatomy, including the blood-retinal barrier (BRB) and blood-aqueous barrier (BAB). The drug delivery system with nanoscale spatial resolution plays an important role in making ocular tissue an important pharmacological target for therapies against disorders.
Some of the major advantages of utilizing the nanotechnology drug delivery system include controlled drug release, promoting absorption, and targeted drug absorption that acts on the target tissues. Nanomaterials can enter the blood capillaries, improve solubility, and reduce drug side effects.
Based on type, the ocular implants market is segmented into nonfunctional implants and functional implants. In 2024, the functional implants segment is expected to account for the largest share of 81.7% of the ocular implants market. The use of functional implants in cosmetic reconstructions, the ability of functional implants to support eye movements, the advantages of functional implants such as their increasing availability and considerable cost, and the high prevalence of eye diseases and disorders contribute to the segment’s large share.
Based on material, the ocular implants market is segmented into inert materials and biointegrated materials. The inert materials segment is further segmented into glass, silicone, and methylmethacrylate. In 2024, the inert materials segment is expected to account for the largest share of the ocular implants market. The large market share of this segment can be attributed to the cost-effectiveness of inert materials and the high preference for glass and silicone material-based ocular implants due to their high compatibility and excellent visual appearance.
Based on application, the ocular implants market is segmented into ocular prosthesis, glaucoma surgery, oculoplasty, drug delivery, and other applications. In 2024, the glaucoma surgery segment is expected to account for the largest share of 32.6% of the ocular implants market. The large market share of this segment can be attributed to the large number of patients affected by glaucoma coupled with increasing cases of glaucoma among the geriatric population and the availability of glaucoma treatment facilities. For instance, according to the October 2022 report of National Glaucoma Research (U.S.), more than 3 million individuals in the U.S. are living with glaucoma, out of which 2.7 million are aged 40 and older. Such instances are expected to support the largest share of the segment.
Based on end user, the ocular implants market is segmented into hospitals, ophthalmic clinics, ambulatory surgery centers (ASCs), and other end users. In 2024, the hospitals segment is expected to account for the largest share of the ocular implants market. The large market share of this segment can be attributed to the easy accessibility to hospitals, the high preference towards hospitals from patients as the first choice for diagnosis and therapies, and the availability of advanced instruments in hospitals.
In 2024, North America is expected to account for the largest share of 41.8% of the ocular implants market, followed by Europe and Asia-Pacific. In North America, the U.S. is expected to account for the largest share in 2024, mainly due to high healthcare expenditure, growth in the aging population, favorable government policies, and the presence of key players in the region.
However, Asia-Pacific is slated to register the highest growth rate of 6.3% during the forecast period 2024–2031 due to growing economies such as India and China. The growth of the ocular implants market in Asia-Pacific is also driven by the increasing geriatric population, the rising prevalence of eye diseases such as glaucoma, infectious endophthalmitis, and other eye diseases, and increasing healthcare expenditures. Rising cases of eye injuries are likely to increase the demand for ocular implants, driving market growth. For instance, according to the Indian Journal of Ophthalmology, eye injuries constitute approximately 38%–65% of emergency cases in hospitals. Thus, the increasing cases of eye injuries are expected to support the growth of the ocular implants market in the region.
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, financials, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the ocular implants market are Alcon Inc. (Switzerland), Bausch + Lomb Corporation (Canada), Carl Zeiss AG (Germany), Johnson & Johnson Vision Care, Inc. (U.S), STAAR SURGICAL COMPANY (U.S), Morcher GmbH (Germany), HOYA CORPORATION (Japan), GLAUKOS CORPORATION (U.S), AbbVie Inc. (U.S.), and Vivani Medical Inc. (U.S).
Particulars |
Details |
Number of Pages |
240 |
Format |
|
Forecast Period |
2024–2031 |
Base Year |
2023 |
CAGR (Value) |
6.1% |
Market Size (Value) |
USD 23.43 Billion by 2031 |
Segments Covered |
By Type
By Material
By Application
By End User
|
Regions/Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Sweden, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa. |
Key Companies Profiled |
Alcon Inc. (Switzerland), Bausch + Lomb Corporation (Canada), Carl Zeiss AG (Germany), Johnson & Johnson Vision Care, Inc. (U.S), STAAR SURGICAL COMPANY (U.S), Morcher GmbH (Germany), HOYA CORPORATION (Japan), GLAUKOS CORPORATION (U.S), AbbVie Inc. (U.S.), and Vivani Medical Inc. (U.S). |
The ocular implants market refers to the global industry focused on producing medical devices implanted in the eye, used for treating various eye disorders, including glaucoma, cataracts, and macular degeneration.
The ocular implants market is expected to reach $23.43 billion by 2031, driven by increasing cases of eye diseases, advancements in technology, and the rising adoption of minimally invasive surgeries.
The market is projected to grow at a CAGR of 6.1% from 2024 to 2031, with North America leading the market due to a higher aging population and advanced healthcare infrastructure.
The global ocular implants market is projected to grow from its current value, reaching $23.43 billion by 2031, driven by technological advancements and an increasing geriatric population.
Key players in the ocular implants market include Alcon Inc., Bausch + Lomb Corporation, Carl Zeiss AG, Johnson & Johnson Vision Care, STAAR Surgical Company, HOYA Corporation, and Glaukos Corporation.
Current trends include AI-driven 3D-printed prosthetic eyes, biomaterial-based implants, and drug-eluting implants that improve the precision and effectiveness of treatments for various eye disorders.
Key drivers include the aging population, rising incidence of eye diseases, technological advancements, growing healthcare expenditure, and the increasing need for minimally invasive surgical procedures.
The market is segmented by type (functional and nonfunctional implants), material (inert and biointegrated materials), application (glaucoma surgery, drug delivery, oculoplasty), and end users (hospitals, ophthalmic clinics, ASCs).
The market is expected to grow globally, with North America leading, while Asia-Pacific is projected to have the highest growth rate due to an increasing geriatric population and rising healthcare expenditures.
The market is expected to grow at a CAGR of 6.1% from 2024 to 2031, driven by the increasing demand for ocular implants in treating eye diseases like glaucoma and cataracts.
The ocular implants market is expected to grow at a CAGR of 6.1% from 2024 to 2031, driven by technological advancements, rising eye disease cases, and increasing demand for minimally invasive surgeries.
North America holds the largest market share, accounting for 41.8% of the ocular implants market in 2024, followed by Europe, while Asia-Pacific is projected to have the highest growth rate during the forecast period.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Factors Affecting Market Growth
4.1. Overview
4.2. Drivers
4.2.1. Rising Geriatric Population Coupled with High Prevalence of Eye Diseases
4.2.2. Rise in Adoption of Minimally Invasive Surgeries
4.2.3. Increasing Healthcare Expenditure
4.2.4. Technological Advancements in Ocular Implants
4.2.5. Increasing Accident Cases Raising the Need for Ocular Implants
4.3. Restraints
4.3.1. Risk of Post-surgery Infections and Inflammations
4.3.2. Lack of Skilled Ophthalmic Surgeons
4.3.3. Strict Regulations and Approval Process
4.4. Opportunities
4.4.1. Ocular Nanotechnology-based Drug Delivery
4.4.2. Ocular Tissue Engineering
4.5. Challenges
4.5.1. Lack of Awareness in Rural Areas
4.5.2. Technological Complexities
4.5.3. High Cost of Implants
4.5.4. Increasing Number of Product Recalls
4.6. Trends
4.6.1. Biomaterial-based Ocular Implants
4.6.2. AI-driven 3D Printed Prosthetic Eyes
4.6.3. Drug-eluting Implants
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Case Studies
4.11. Porter’s Five Forces Analysis
5. Ocular Implants Market Assessment, by Type
5.1. Overview
5.2. Non Functional Implants
5.2.1. Ocular Implant
5.2.1.1. Scleral Shells
5.2.1.2. Stock Shells
5.2.1.3. Custom Made Prosthesis
5.2.2. Orbital Implants
5.3. Functional Implants
5.3.1. Intraocular Lens
5.3.2. Glaucoma Implants
5.3.3. Retinal Implants
5.3.4. Corneal Implants
6. Ocular Implants Market Assessment, by Material
6.1. Overview
6.2. Inert materials
6.2.1. Glass
6.2.2. Silicone
6.2.3. Methylmethacrylate
6.3. Biointegrated Materials
6.3.1. Hydroxyapatite
6.3.2. Porous Polyethylene
6.3.3. Aluminum Oxide
7. Ocular Implants Market Assessment, by Application
7.1. Overview
7.2. Ocular Prosthesis
7.3. Glaucoma Surgery
7.4. Oculoplasty
7.5. Drug Delivery
7.6. Other Applications
8. Ocular Implants Market Assessment, by End User
8.1. Overview
8.2. Hospitals
8.3. Ophthalmic Clinics
8.4. Ambulatory Surgery Centers (ASCs)
8.5. Other End Users
9. Ocular Implants Market Assessment, by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Netherlands
9.3.7. Switzerland
9.3.8. Sweden
9.3.9. Belgium
9.3.10. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (RoLATAM)
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis of Key Players (2023)
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Alcon Inc.
11.2. Bausch + Lomb Corporation
11.3. Carl Zeiss AG
11.4. Johnson & Johnson Vision Care, Inc.
11.5. STAAR Surgical Company
11.6. Morcher GmbH
11.7. Hoya Corporation
11.8. Glaukos Corporation
11.9. ABBVIE INC.
11.10. Vivani Medical Inc.
(Note: SWOT analyses of the top 5 companies will be provided.
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 2 Global Non-functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 3 Global Non-functional Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 5 Global Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Scleral Shells Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Stock Shells Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Custom Made Prosthesis Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Orbital Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 11 Global Functional Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Intraocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Glaucoma Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Retinal Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Corneal Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Ocular Implants Market, by Materials, 2022–2031 (USD Million)
Table 17 Global Inert Materials Based Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 18 Global Inert Materials Based Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Glass Based Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Silicone Based Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Methylmethacrylate Based Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Biointegrated Ocular Implant Materials Market, by Type, 2022–2031 (USD Million)
Table 23 Global Biointegrated Ocular Implant Materials Market, by Country/Region, 2022–2031 (USD Million
Table 24 Global Hydroxyapatite Ocular Implants Market, by Country/Region, 2022–2031 (USD Million
Table 25 Global Porous Polyethylene Ocular Implants Market, by Country/Region, 2022–2031 (USD Million
Table 26 Global Aluminum Oxide Ocular Implants Market, by Country/Region, 2022–2031 (USD Million
Table 27 Global Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 28 Global Ocular Implants Market for Ocular Prosthesis, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Ocular Implants Market for Glaucoma Surgery, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Ocular Implants Market for Oculoplasty, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Ocular Implants Market for Drug Delivery, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Ocular Implants Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 34 Global Ocular Implants Market for Hospitals, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Ocular Implants Market for Ophthalmic Clinics, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Ocular Implants Market for Ambulatory Surgery Centers (ASCs), by Country/Region, 2022–2031 (USD Millon)
Table 37 Global Ocular Implants Market for Other End Users, by Country/Region, 2022–2031 (USD Millon)
Table 38 Global Ocular Implants Market, by Country/Region, 2022–2031 (USD Million).
Table 39 North America: Ocular Implants Market, by Country, 2022–2031 (USD Million)
Table 40 North America: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 41 North America: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 42 North America: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 43 North America: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 44 North America: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 45 North America: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 46 North America: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 47 North America: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 48 North America: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 49 U.S.: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 50 U.S.: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 51 U.S.: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 52 U.S.: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 53 U.S.: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 54 U.S.: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 55 U.S.: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 56 U.S.: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 57 U.S.: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 58 Canada: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 59 Canada: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 60 Canada: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 61 Canada: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 62 Canada: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 63 Canada: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 64 Canada: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 65 Canada: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 66 Canada: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 67 Europe: Ocular Implants Market, by Country/Region, 2022–2031 (USD Million))
Table 68 Europe: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 69 Europe: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 70 Europe: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 71 Europe: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 72 Europe: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 73 Europe: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 74 Europe: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 75 Europe: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 76 Europe: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 77 Germany: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 78 Germany: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 79 Germany: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 80 Germany: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 81 Germany: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 82 Germany: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 83 Germany: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 84 Germany: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 85 Germany: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 86 France: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 87 France: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 88 France: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 89 France: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 90 France: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 91 France: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 92 France: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 93 France: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 94 France: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 95 U.K.: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 96 U.K.: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 97 U.K.: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 98 U.K.: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 99 U.K.: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 100 U.K.: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 101 U.K.: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 102 U.K.: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 103 U.K.: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 104 Italy: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 105 Italy: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 106 Italy: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 107 Italy: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 108 Italy: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 109 Italy: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 110 Italy: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 111 Italy: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 112 Italy: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 113 Spain: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 114 Spain: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 115 Spain: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 116 Spain: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 117 Spain: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 118 Spain: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 119 Spain: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 120 Spain: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 121 Spain: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 122 Netherlands: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 123 Netherlands: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 124 Netherlands: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 125 Netherlands: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 126 Netherlands: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 127 Netherlands: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 128 Netherlands: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 129 Netherlands: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 130 Netherlands: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 131 Switzerland: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 132 Switzerland: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 133 Switzerland: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 134 Switzerland: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 135 Switzerland: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 136 Switzerland: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 137 Switzerland: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 138 Switzerland: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 139 Switzerland: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 140 Sweden: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 141 Sweden: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 142 Sweden: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 143 Sweden: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 144 Sweden: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 145 Sweden: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 146 Sweden: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 147 Sweden: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 148 Sweden: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 149 Belgium: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 150 Belgium: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 151 Belgium: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 152 Belgium: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 153 Belgium: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 154 Belgium: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 155 Belgium: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 156 Belgium: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 157 Belgium: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 158 Rest of Europe (RoE): Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 159 Rest of Europe (RoE): Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 160 Rest of Europe (RoE): Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 161 Rest of Europe (RoE): Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 162 Rest of Europe (RoE): Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 163 Rest of Europe (RoE): Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 164 Rest of Europe (RoE): Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 165 Rest of Europe (RoE): Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 166 Rest of Europe (RoE): Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 167 Asia-Pacific: Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 168 Asia-Pacific: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 169 Asia-Pacific: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 170 Asia-Pacific: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 171 Asia-Pacific: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 172 Asia-Pacific: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 173 Asia-Pacific: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 174 Asia-Pacific: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 175 Asia-Pacific: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 176 Asia-Pacific: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 177 Japan: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 178 Japan: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 179 Japan: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 180 Japan: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 181 Japan: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 182 Japan: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 183 Japan: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 184 Japan: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 185 Japan: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 186 China: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 187 China: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 188 China: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 189 China: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 190 China: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 191 China: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 192 China: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 193 China: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 194 China: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 195 India: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 196 India: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 197 India: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 198 India: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 199 India: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 200 India: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 201 India: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 202 India: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 203 India: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 204 Australia: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 205 Australia: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 206 Australia: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 207 Australia: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 208 Australia: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 209 Australia: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 210 Australia: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 211 Australia: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 212 Australia: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 213 South Korea: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 214 South Korea: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 215 South Korea: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 216 South Korea: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 217 South Korea: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 218 South Korea: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 219 South Korea: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 220 South Korea: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 221 South Korea: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 222 Rest of Asia-Pacific (RoAPAC): Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 223 Rest of Asia-Pacific (RoAPAC): Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 224 Rest of Asia-Pacific (RoAPAC): Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 225 Rest of Asia-Pacific (RoAPAC): Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 226 Rest of Asia-Pacific (RoAPAC): Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 227 Rest of Asia-Pacific (RoAPAC): Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 228 Rest of Asia-Pacific (RoAPAC): Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 229 Rest of Asia-Pacific (RoAPAC): Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 230 Rest of Asia-Pacific (RoAPAC): Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 231 Latin America: Ocular Implants Market, by Country/Region, 2022–2031 (USD Million)
Table 232 Latin America: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 233 Latin America: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 234 Latin America: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 235 Latin America: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 236 Latin America: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 237 Latin America: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 238 Latin America: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 239 Latin America: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 240 Latin America: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 241 Brazil: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 242 Brazil: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 243 Brazil: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 244 Brazil: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 245 Brazil: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 246 Brazil: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 247 Brazil: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 248 Brazil: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 249 Brazil: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 250 Mexico: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 251 Mexico: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 252 Mexico: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 253 Mexico: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 254 Mexico: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 255 Mexico: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 256 Mexico: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 257 Mexico: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 258 Mexico: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 259 Rest of Latin America (ROLATAM): Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 260 Rest of Latin America (ROLATAM): Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 261 Rest of Latin America (ROLATAM): Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 262 Rest of Latin America (ROLATAM): Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 263 Rest of Latin America (ROLATAM): Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 264 Rest of Latin America (ROLATAM): Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 265 Rest of Latin America (ROLATAM): Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 266 Rest of Latin America (ROLATAM): Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 267 Rest of Latin America (ROLATAM): Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 268 Middle East & Africa: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 269 Middle East & Africa: Non Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 270 Middle East & Africa: Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 271 Middle East & Africa: Functional Ocular Implants Market, by Type, 2022–2031 (USD Million)
Table 272 Middle East & Africa: Ocular Implants Market, by Material, 2022–2031 (USD Million)
Table 273 Middle East & Africa: Inert Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 274 Middle East & Africa: Biointegrated Ocular Implants Material Market, by Type, 2022–2031 (USD Million)
Table 275 Middle East & Africa: Ocular Implants Market, by Application, 2022–2031 (USD Million)
Table 276 Middle East & Africa: Ocular Implants Market, by End User, 2022–2031 (USD Million)
Table 277 Recent Developments, by Company (2020–2024)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Source
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Ocular Implants Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 8 Global Ocular Implants Market, by Material, 2024 Vs. 2031 (USD Million)
Figure 9 Global Ocular Implants Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 10 Global Ocular Implants Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Global Ocular Implants Market, by Geography
Figure 12 Impact Analysis: Ocular Implants Market
Figure 13 Global Ocular Implants Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 14 Global Ocular Implants Market, by Material, 2024 Vs. 2031 (USD Million)
Figure 15 Global Ocular Implants Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 16 Global Ocular Implants Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 17 Global Ocular Implants Market, by Region, 2024 Vs. 2031 (USD Million)
Figure 18 North America: Ocular Implants Market Snapshot
Figure 19 Europe: Ocular Implants Market Snapshot
Figure 20 Asia Pacific: Ocular Implants Market Snapshot
Figure 21 Latin America: Ocular Implants Market Snapshot
Figure 22 Recent Developments, by Company, (2020–2024)
Figure 23 Global Ocular Implants Market: Competitive Benchmarking, By Type
Figure 24 Global Ocular Implants Market: Competitive Benchmarking, By Region
Figure 25 Bausch + Lomb Corporation: Financial Overview (2023)
Figure 26 Alcon Inc.: Financial Overview (2023)
Figure 27 Carl Zeiss AG: Financial Overview (2023)
Figure 28 Johnson & Johnson Vision Care, Inc.: Financial Overview (2023)
Figure 29 STAAR Surgical Company: Financial Overview (2023)
Figure 30 Hoya Corporation: Financial Overview (2023)
Figure 31 Glaukos Corporation: Financial Overview (2023)
Figure 32 ABBVIE INC.: Financial Overview (2023)
Figure 33 Vivani Medical Inc.: Financial Overview (2023)
Published Date: Jan-2024
Published Date: Sep-2024
Published Date: May-2024
Published Date: Apr-2023
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates